31 related articles for article (PubMed ID: 38014033)
1. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.
Barkan D; Kleinman H; Simmons JL; Asmussen H; Kamaraju AK; Hoenorhoff MJ; Liu ZY; Costes SV; Cho EH; Lockett S; Khanna C; Chambers AF; Green JE
Cancer Res; 2008 Aug; 68(15):6241-50. PubMed ID: 18676848
[TBL] [Abstract][Full Text] [Related]
2. The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion.
Dehainault C; Garancher A; Castéra L; Cassoux N; Aerts I; Doz F; Desjardins L; Lumbroso L; Montes de Oca R; Almouzni G; Stoppa-Lyonnet D; Pouponnot C; Gauthier-Villars M; Houdayer C
Hum Mol Genet; 2014 Oct; 23(19):5243-50. PubMed ID: 24858910
[TBL] [Abstract][Full Text] [Related]
3. Differences in integrin expression and signaling within human breast cancer cells.
Taherian A; Li X; Liu Y; Haas TA
BMC Cancer; 2011 Jul; 11():293. PubMed ID: 21752268
[TBL] [Abstract][Full Text] [Related]
4. Myocardin-related transcription factor's interaction with serum-response factor is critical for outgrowth initiation, progression, and metastatic colonization of breast cancer cells.
Gau D; Chawla P; Eder I; Roy P
FASEB Bioadv; 2022 Aug; 4(8):509-523. PubMed ID: 35949508
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.
Wendt MK; Taylor MA; Schiemann BJ; Schiemann WP
Mol Biol Cell; 2011 Jul; 22(14):2423-35. PubMed ID: 21613543
[TBL] [Abstract][Full Text] [Related]
6. Noncanonical Activity of Med4 as a Gatekeeper of Metastasis through Epigenetic Control of Integrin Signaling.
Bae SY; Chen Y; Chen H; Kumar D; Karaiskos S; Xu J; Lu C; Viny AD; Giancotti FG
bioRxiv; 2024 Jan; ():. PubMed ID: 38014033
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.
Barkan D; Green JE; Chambers AF
Eur J Cancer; 2010 May; 46(7):1181-8. PubMed ID: 20304630
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications.
Robinson NJ; Parker KA; Schiemann WP
Ann Transl Med; 2020 Jul; 8(14):903. PubMed ID: 32793747
[TBL] [Abstract][Full Text] [Related]
10. The Role of the ECM in Lung Cancer Dormancy and Outgrowth.
Parker AL; Cox TR
Front Oncol; 2020; 10():1766. PubMed ID: 33014869
[TBL] [Abstract][Full Text] [Related]
11. Engineered
Pradhan S; Sperduto JL; Farino CJ; Slater JH
J Biol Eng; 2018; 12():37. PubMed ID: 30603045
[TBL] [Abstract][Full Text] [Related]
12. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.
Yadav AS; Pandey PR; Butti R; Radharani NNV; Roy S; Bhalara SR; Gorain M; Kundu GC; Kumar D
Front Oncol; 2018; 8():72. PubMed ID: 29616190
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
